Influence of a long-term zinc-deficient diet on rat platelet function and fatty acid composition.
A reduced zinc intake is associated with numerous abnormalities and, in particular, with hemostasis dysfunction. In this report, we studied the effects of a long-term dietary zinc restriction on platelet function. Three groups of rats were analyzed: a zinc-deficient group (ZD) and two zinc-adequate fed groups, one pair-fed (PF) and one ad libitum fed (AL). We found that ZD diet (0.2 p.p.m.) impaired ADP-induced aggregation of washed platelet after 4 and 8 weeks of diet. Thrombin-induced aggregation was impaired in ZD rats and PF rats after 8 weeks. The thrombin-induced mobilization of radiolabeled arachidonate preincorporated into platelet phospholipids was followed as well as the subsequent formation of labeled cyclooxygenase and lipoxygenase products. Stimulated platelets of ZD rats exhibited a decreased production of cyclooxygenase and lipoxygenase products, particularly after 8 weeks of diet. Moreover, platelet thromboxane generation was decreased in the ZD group as studied using a radioimmunoassay after thrombin stimulation. In addition, we measured the total fatty acid compositions of platelet and plasma. As a whole, 20:5 (n - 3) and 22:5 (n - 3) fatty acids content were significantly increased in platelet lipids after 8 weeks. On the other hand, it is known that enrichment of these fatty acids through dietary studies, both in animal and human as well as in vitro incorporation in platelets, resulted in an inhibition of platelet function. Consequently, these changes in platelet membrane fatty acid composition may contribute to the impaired platelet aggregation observed in ZD rats.
Faure
P
P
Laboratoire de Biochimie C, Hopital A. Michallon, Grenoble, France.
Durand
P
P
Blache
D
D
Favier
A
A
Roussel
A M
AM
D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D000818:Animals; D016718:Arachidonic Acid / Q000097:blood*; D001792:Blood Platelets / Q000737:chemistry / Q000187:drug effects / Q000502:physiology*; D001842:Bone and Bones / Q000378:metabolism*; D004032:Diet; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D006893:Hydroxyeicosatetraenoic Acids / Q000097:blood; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values; D013917:Thrombin / Q000494:pharmacology; D013929:Thromboxane B2 / Q000097:blood; D015032:Zinc / Q000008:administration & dosage / Q000097:blood / Q000172:deficiency* / Q000378:metabolism / Q000494:pharmacology
D005230:Fatty Acids, Nonesterified; D006893:Hydroxyeicosatetraenoic Acids; D016718:Arachidonic Acid; D013929:Thromboxane B2; D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D013917:Thrombin; D015032:Zinc